As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles now introduces customized Metal Organic Frameworks (MOFs) materials with various material formats and chemical composition to help researchers solve challenges they might meet, such as limited MOF options in the market for different applications, restricted surface area, and low production yield and low consistency. These MOFs can be possibly applied in drug delivery, gas and liquid adsorption, gas storage, catalysis, and sensing and detection.
Free of tedious processing and formulation and limited facilities for large production yield with consistant quality control, researchers are now accessible to various materals at CD Bioparticles, like Iron-based MOFs, Zinc-Based MOFs, Cobalt-based MOFs, Nickel-based MOFs, Indium-based MOFs, and Titanium-based MOFs. With this new release of these MOFs materials, at CD Bioparticles researchers can gain a lot of benefits such as wide coverage of the MOFs and free choice of building blocks, pursuing higher surface area with optimized formulation, cost-effective MOF manufacturing at scale, and tailored textural properties and uncompromising on porosity.
“We are glad to support scientists and to provide them with access to the efficient and productive MOF-based adsorption system and with cost-effective MOF manufacturing at scale, which can help them achieve their next breakthrough faster. In addition, we can ensure customers the supply of highly-porous, suitably robust, shaped MOFs, all of which are tailored to their applications, such as membrane separation, sensors and biotech.” said Prof. Jeffrey A. Depaul, M.D., the chief scientific officer of R&D department of CD Bioparticles.
“Despite of the MOFs, CD Bioparticles is driven to provide more research solutions and technology that will enable our customers to generate reliable results faster in their projects. The demand is urgent and we’ll continue to innovate by expanding our portfolio of porous organic materials to assist their work.” said Dr. Robin J. Watts, the scientific officer of R&D department of CD Bioparticles.
For more detailed information on metal-organic frameworks materials, please contact CD Bioparticles directly at contact ( @ ) cd-bioparticles dot com dot
About CD Bioparticles
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.